Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease.

Kalayjian RC, Spritzler J, Pu M, Landay A, Pollard RB, Stocker V, Harthi LA, Gross BH, Francis IR, Fiscus SA, Tebas P, Bosch RJ, Valcour V, Lederman MM; Adult AIDS Clinical Trials Group 5015 and 5113 Study Teams..

J Infect Dis. 2005 Nov 1;192(9):1577-87. Epub 2005 Sep 29.

PMID:
16206072
2.

Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy.

Ruiz-Mateos E, de la Rosa R, Franco JM, Martinez-Moya M, Rubio A, Soriano N, Sanchez-Quijano A, Lissen E, Leal M.

AIDS. 2003 May 2;17(7):947-54.

PMID:
12700443
3.

Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.

Marchetti G, Gori A, Casabianca A, Magnani M, Franzetti F, Clerici M, Perno CF, Monforte Ad, Galli M, Meroni L.

AIDS. 2006 Aug 22;20(13):1727-36.

PMID:
16931937
4.

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.

Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, Schlub TE, Davenport M, Crowe S, Elliott J, Hoy J, Fairley C, Stewart G, Cameron P, Lewin SR.

J Infect Dis. 2010 Oct 15;202(8):1254-64. doi: 10.1086/656369.

PMID:
20812848
5.

Thymic volume predicts CD4 T-cell decline in HIV-infected adults under prolonged treatment interruption.

Molina-Pinelo S, Vivancos J, De Felipe B, Soriano-Sarabia N, Valladares A, De la Rosa R, Vallejo A, Leal M.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):203-6.

PMID:
16760798
6.

Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.

Beq S, Delfraissy JF, Theze J.

Eur Cytokine Netw. 2004 Oct-Dec;15(4):279-89. Review.

7.

HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.

Kolte L, Ryder LP, Albrecht-Beste E, Jensen FK, Nielsen SD.

Scand J Immunol. 2009 Dec;70(6):608-13. doi: 10.1111/j.1365-3083.2009.02328.x.

8.

Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.

Delobel P, Nugeyre MT, Cazabat M, Sandres-Sauné K, Pasquier C, Cuzin L, Marchou B, Massip P, Cheynier R, Barré-Sinoussi F, Izopet J, Israël N.

J Virol. 2006 Oct;80(20):10229-36.

9.

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.

J Infect Dis. 2006 Jul 1;194(1):29-37. Epub 2006 May 18.

PMID:
16741879
10.

Increases in CD4+ T lymphocytes occur without increases in thymic size in HIV-infected subjects receiving interleukin-2 therapy.

Lu AC, Jones EC, Chow C, Miller KD, Herpin B, Rock-Kress D, Metcalf JA, Lane HC, Kovacs JA.

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):299-303.

PMID:
14600575
11.

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.

Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E, Kuritzkes D, Gross B, Francis I, McCune JM, Lederman MM.

J Infect Dis. 2000 Jan;181(1):141-7.

PMID:
10608760
12.

T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.

Marziali M, De Santis W, Carello R, Leti W, Esposito A, Isgrò A, Fimiani C, Sirianni MC, Mezzaroma I, Aiuti F.

AIDS. 2006 Oct 24;20(16):2033-41.

PMID:
17053349
13.
14.

Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.

Landay A, da Silva BA, King MS, Albrecht M, Benson C, Eron J, Glesby M, Gulick R, Hicks C, Kessler H, Murphy R, Thompson M, White AC Jr, Wolfe P, McMillan FI, Hanna GJ.

Clin Infect Dis. 2007 Mar 1;44(5):749-54. Epub 2007 Jan 25.

PMID:
17278071
15.

Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.

Molina-Pinelo S, Vallejo A, Díaz L, Soriano-Sarabia N, Ferrando-Martínez S, Resino S, Muñoz-Fernández MA, Leal M.

J Antimicrob Chemother. 2009 Sep;64(3):579-88. doi: 10.1093/jac/dkp248. Epub 2009 Jul 16.

PMID:
19608579
16.

Thymic function in HIV-infection.

Kolte L.

Dan Med J. 2013 Apr;60(4):B4622. Review.

PMID:
23651726
17.
18.

Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.

De Rossi A, Walker AS, De Forni D, Klein N, Gibb DM; Paediatric European Network for Treatment of AIDS..

Antivir Ther. 2005;10(1):63-71.

PMID:
15751764
19.

Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.

Pratesi C, Simonelli C, Zanussi S, Talamini R, Bortolin MT, Tedeschi R, Marus A, Caffau C, Michieli M, Tirelli U, De Paoli P.

Clin Exp Immunol. 2008 Jan;151(1):101-9. Epub 2007 Oct 11.

20.

Evidence of thymic function in heavily antiretroviral-treated human immunodeficiency virus type 1-infected adults with long-term virologic treatment failure.

Delgado J, Leal M, Ruiz-Mateos E, Martínez-Moya M, Rubio A, Merchante E, de la Rosa R, Sánchez-Quijano A, Lissen E.

J Infect Dis. 2002 Aug 1;186(3):410-4. Epub 2002 Jul 5.

PMID:
12134238

Supplemental Content

Support Center